Aspergillosis in solid organ transplantation (Q42272291)

19 October 2017

Aspergillosis in solid organ transplantation (English)

1 reference

AST Infectious Diseases Community of Practice

19 October 2017

0 references

organ transplantation

1 reference

based on heuristic

inferred from title

author

series ordinal

3

object named as

AST Infectious Diseases Community of Practice

1 reference

19 October 2017

N Singh

1

1 reference

PubMed ID

23465016

19 October 2017

S Husain

series ordinal

2

1 reference

PubMed ID

23465016

19 October 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

American Journal of Transplantation

19 October 2017

1 reference

19 October 2017

13 Suppl 4

1 reference

19 October 2017

228-241

1 reference

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

19 October 2017

1 reference

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry

21 January 2018

1 reference

Invasive aspergillosis in transplant recipients

21 January 2018

1 reference

Incidence and significance of Aspergillus cultures following liver and kidney transplantation

21 January 2018

1 reference

Risk factors for systemic fungal infections in liver transplant recipients

21 January 2018

1 reference

Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation

21 January 2018

1 reference

Aspergillus infections in transplant recipients

21 January 2018

1 reference

Risk factors for invasive aspergillosis in liver transplant recipients

21 January 2018

1 reference

Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy

21 January 2018

1 reference

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.

21 January 2018

1 reference

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

21 January 2018

1 reference

Risk factors for invasive fungal infections complicating orthotopic liver transplantation.

21 January 2018

1 reference

Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression

21 January 2018

1 reference

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients

21 January 2018

1 reference

Systemic fungal infections after renal transplantation

21 January 2018

1 reference

Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management.

21 January 2018

1 reference

Invasive Aspergillosis in Renal Transplant Recipients: Correlation with Corticosteroid Therapy

21 January 2018

1 reference

Outbreak of invasive aspergillosis among renal transplant recipients

21 January 2018

1 reference

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

21 January 2018

1 reference

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

21 January 2018

1 reference

Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.

21 January 2018

1 reference

Hypogammaglobulinemia in lung transplant recipients

21 January 2018

1 reference

Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients.

21 January 2018

1 reference

Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients

21 January 2018

1 reference

Infections in lung allograft recipients: ganciclovir era.

21 January 2018

1 reference

Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?

21 January 2018

1 reference

Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis

21 January 2018

1 reference

The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis.

21 January 2018

1 reference

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients

21 January 2018

1 reference

Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature

21 January 2018

1 reference

Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients

21 January 2018

1 reference

Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients

21 January 2018

1 reference

Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients.

21 January 2018

1 reference

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

21 January 2018

1 reference

Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients

21 January 2018

1 reference

Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid

21 January 2018

1 reference

Risk factors and impact of beta-D glucan on invasive fungal infection for the living donor liver transplant recipients

21 January 2018

1 reference

The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation

21 January 2018

1 reference

Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients.

21 January 2018

1 reference

Radiological and clinical findings of pulmonary aspergillosis following solid organ transplant

21 January 2018

1 reference

Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.

21 January 2018

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

Voriconazole in the treatment of invasive mold infections in transplant recipients.

21 January 2018

1 reference

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

21 January 2018

1 reference

Aspergillus fumigatus-related spondylodiscitis in a heart transplant patient successfully treated with voriconazole.

21 January 2018

1 reference

Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation

21 January 2018

1 reference

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

21 January 2018

1 reference

Antifungal management practices in liver transplant recipients

21 January 2018

1 reference

Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole

21 January 2018

1 reference

Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report

21 January 2018

1 reference

Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

21 January 2018

1 reference

Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients

21 January 2018

1 reference

Enhanced cyclosporine-itraconazole interaction with cola in lung transplant recipients

21 January 2018

1 reference

Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis

21 January 2018

1 reference

Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.

21 January 2018

1 reference

Safety and tolerability of caspofungin acetate in the treatment of fungal infections

21 January 2018

1 reference

Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections

21 January 2018

1 reference

Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infection

21 January 2018

1 reference

Anidulafungin: a novel echinocandin

21 January 2018

1 reference

Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine

21 January 2018

1 reference

Micafungin: a new echinocandin antifungal

21 January 2018

1 reference

Concomitant cyclosporine and micafungin pharmacokinetics in healthy volunteers

21 January 2018

1 reference

Micafungin: a new echinocandin

21 January 2018

1 reference

Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes

21 January 2018

1 reference

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

21 January 2018

1 reference

Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases

21 January 2018

1 reference

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients

21 January 2018

1 reference

Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens

21 January 2018

1 reference

Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis

21 January 2018

1 reference

A case of invasive aspergillosis in CGD patient successfully treated with Amphotericin B and INF-gamma

21 January 2018

1 reference

Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease

21 January 2018

1 reference

Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis

21 January 2018

1 reference

Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation

21 January 2018

1 reference

Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients

21 January 2018

1 reference

Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients

21 January 2018

1 reference

Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation

21 January 2018

1 reference

Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients

21 January 2018

1 reference

The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants

21 January 2018

1 reference

Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors

21 January 2018

1 reference

Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group

21 January 2018

1 reference

Safety of aerosolized amphotericin B lipid complex in lung transplant recipients

21 January 2018

1 reference

Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients

21 January 2018

1 reference

Diagnosis and outcome of early pleural space infection following lung transplantation.

21 January 2018

1 reference

Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipients.

21 January 2018

1 reference

Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.

21 January 2018

1 reference

Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients

21 January 2018

1 reference

High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients

21 January 2018

1 reference

Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients

21 January 2018

1 reference

Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients

21 January 2018

1 reference

Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study

21 January 2018

1 reference

Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients

21 January 2018

1 reference

Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study

21 January 2018

1 reference

Treatment of deep mycoses with liposomal amphotericin B

21 January 2018

1 reference

Safety of anidulafungin in solid organ transplant recipients

21 January 2018

1 reference

Cure of Disseminated Cryptococcal Infection in a Renal Allograft Recipient After Addition of gamma-Interferon to Anti-Fungal Therapy

21 January 2018

1 reference

Voriconazole Prophylaxis in Lung Transplant Recipients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.12115

1 reference

19 October 2017

1 reference

PubMed ID

23465016